Evidence map›Paper›PMID 25079105›Full record

SynthesisAnnals of the American Thoracic Society2014

Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review.

Andrew C Miller, Markku Miettinen, David S Schrump, Raffit Hassan

Open access · greenAbstract readCase ReportsSystematic Review
In one paragraph

Synthesis in Annals of the American Thoracic Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Cerebral metastases of malignant mesothelioma.Journal of surgical case reports · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Mesothelium and Malignant Mesothelioma.Journal of developmental biology · 2019
    Review
  14. Article
  15. Proton beam therapy for malignant pleural mesothelioma.Translational lung cancer research · 2018
    Review
  16. Brain metastases in malignant pleural mesothelioma.Clinical & experimental metastasis · 2016
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Andrew C Miller1 Critical Care Medicine Department, Clinical Center.
Markku Miettinen
David S Schrump
Raffit Hassan
National Institutes of Health · USCenter for Clinical Research (United States) · USNational Cancer Institute · MY

Funding

Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic MalignanciesZIABC010816 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HASSAN, RAFFIT · 2009 to 2025
$25.5M
Thoracic and Gastrointestinal Oncology Branch Medical Clinical CoreZIDBC011540 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HASSAN, RAFFIT · 2014 to 2025
$17.7M
6 · The paper itself

Abstract

rationaleThe incidence and patterns of metastatic disease to the central nervous system (CNS) from malignant mesothelioma are not well characterized.

objectivesWe describe the treatment of two cases of pleural mesothelioma with CNS metastases. We also report the results of a systematic review with pooled data analysis of CNS metastases from malignant mesothelioma.

methodsPubMed, Scopus, EMBASE, and Web of Science were searched to identify relevant published studies. Inclusion criteria for the pooled analysis were any clinical or autopsy study in which patients had a confirmed histological diagnosis of malignant mesothelioma and CNS metastasis was identified by autopsy, clinical pathological specimen, or compelling radiographic imaging. Case reports were excluded from the pooled analysis but were incorporated into the discussion. One hundred forty-one potentially relevant references were identified. Seven studies including 655 patients were included in the pooled analysis. Ninety-seven additional cases were identified and incorporated into the discussion. A systematic review of the literature is provided with pooled data analysis. MEASUREMENTS AND MAIN

resultsCNS involvement of malignant mesothelioma may occur by hematogenous spread or by local extension. Some cases may represent tumor dedifferentiation to a more aggressive histologic subtype. Surgery or stereotactic therapies may play a role for select patients; however, rapid recurrence has been reported.

conclusionsThe prognostic significance of CNS disease is not well characterized. Clinicians should consider and identify CNS involvement in patients with new or evolving neurologic symptoms because early identification may allow for palliative intervention.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsBrain NeoplasmsCombined Modality TherapyDisease ProgressionFatal OutcomeHumansLung NeoplasmsMaleMesotheliomaMesothelioma, MalignantMiddle AgedNeoplasm InvasivenessNeoplasm StagingPleural NeoplasmsRadiosurgerybraincentral nervous systemmalignant mesotheliomaspine

Identifiers

PMID25079105
PMCPMC4214057
OpenAlexW2107264627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.